MENU
ALGS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aligos Therapeutics (ALGS) Ownership - Who owns Aligos Therapeutics?

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections... Show more

Profile

Industry
N/A
Address
One Corporate Drive
Phone
+1 800 466-6059
Employees
82
Web
https://www.aligos.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
25.42M
P/E Ratio
-0.53
Total Cash
30.38M
Projected Growth
N/A
Total Debt
3.5M
Revenue
31.52M
Risk (Beta)
2.60
Dividend Yield
N/A
Total Cash/Share
4.87
Total Debt/Equity
N/A
Revenue/Share
3.03 USD as % of share price
Who owns Aligos Therapeutics? ALGS symbol Ownership - Tickeron.com